Hypermethylation of the <it>DLC1 </it>CpG island does not alter gene expression in canine lymphoma
<p>Abstract</p> <p>Background</p> <p>This study is a comparative epigenetic evaluation of the methylation status of the <it>DLC1 </it>tumor suppressor gene in naturally-occurring canine lymphoma. Canine non-Hodgkin's lymphoma (NHL) has been proposed to...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-11-01
|
Series: | BMC Genetics |
Online Access: | http://www.biomedcentral.com/1471-2156/10/73 |
id |
doaj-a8c9699174a64155b57e585692e193bb |
---|---|
record_format |
Article |
spelling |
doaj-a8c9699174a64155b57e585692e193bb2020-11-25T03:29:30ZengBMCBMC Genetics1471-21562009-11-011017310.1186/1471-2156-10-73Hypermethylation of the <it>DLC1 </it>CpG island does not alter gene expression in canine lymphomaRahmatpanah FarahHenry Carolyn JRissetto Kerry CTaylor Kristen HArthur Gerald LBerent Linda MJabbes MohamedBryan Jeffrey NRankin Wendi VVillamil Jose ALewis Michael RCaldwell Charles W<p>Abstract</p> <p>Background</p> <p>This study is a comparative epigenetic evaluation of the methylation status of the <it>DLC1 </it>tumor suppressor gene in naturally-occurring canine lymphoma. Canine non-Hodgkin's lymphoma (NHL) has been proposed to be a relevant preclinical model that occurs spontaneously and may share causative factors with human NHL due to a shared home environment. The canine <it>DLC1 </it>mRNA sequence was derived from normal tissue. Using lymphoid samples from 21 dogs with NHL and 7 normal dogs, the methylation status of the promoter CpG island of the gene was defined for each sample using combined bisulfite restriction analysis (COBRA), methylation-specific PCR (MSP), and bisulfite sequencing methods. Relative gene expression was determined using real-time PCR.</p> <p>Results</p> <p>The mRNA sequence of canine <it>DLC1 </it>is highly similar to the human orthologue and contains all protein functional groups, with 97% or greater similarity in functional regions. Hypermethylation of the 5' and 3' flanking regions of the promoter was statistically significantly associated with the NHL phenotype, but was not associated with silencing of expression or differences in survival.</p> <p>Conclusion</p> <p>The canine <it>DLC1 </it>is constructed highly similarly to the human gene, which has been shown to be an important tumor suppressor in many forms of cancer. As in human NHL, the promoter CpG island of <it>DLC1 </it>in canine NHL samples is abnormally hypermethylated, relative to normal lymphoid tissue. This study confirms that hypermethylation occurs in canine cancers, further supporting the use of companion dogs as comparative models of disease for evaluation of carcinogenesis, biomarker diagnosis, and therapy.</p> http://www.biomedcentral.com/1471-2156/10/73 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rahmatpanah Farah Henry Carolyn J Rissetto Kerry C Taylor Kristen H Arthur Gerald L Berent Linda M Jabbes Mohamed Bryan Jeffrey N Rankin Wendi V Villamil Jose A Lewis Michael R Caldwell Charles W |
spellingShingle |
Rahmatpanah Farah Henry Carolyn J Rissetto Kerry C Taylor Kristen H Arthur Gerald L Berent Linda M Jabbes Mohamed Bryan Jeffrey N Rankin Wendi V Villamil Jose A Lewis Michael R Caldwell Charles W Hypermethylation of the <it>DLC1 </it>CpG island does not alter gene expression in canine lymphoma BMC Genetics |
author_facet |
Rahmatpanah Farah Henry Carolyn J Rissetto Kerry C Taylor Kristen H Arthur Gerald L Berent Linda M Jabbes Mohamed Bryan Jeffrey N Rankin Wendi V Villamil Jose A Lewis Michael R Caldwell Charles W |
author_sort |
Rahmatpanah Farah |
title |
Hypermethylation of the <it>DLC1 </it>CpG island does not alter gene expression in canine lymphoma |
title_short |
Hypermethylation of the <it>DLC1 </it>CpG island does not alter gene expression in canine lymphoma |
title_full |
Hypermethylation of the <it>DLC1 </it>CpG island does not alter gene expression in canine lymphoma |
title_fullStr |
Hypermethylation of the <it>DLC1 </it>CpG island does not alter gene expression in canine lymphoma |
title_full_unstemmed |
Hypermethylation of the <it>DLC1 </it>CpG island does not alter gene expression in canine lymphoma |
title_sort |
hypermethylation of the <it>dlc1 </it>cpg island does not alter gene expression in canine lymphoma |
publisher |
BMC |
series |
BMC Genetics |
issn |
1471-2156 |
publishDate |
2009-11-01 |
description |
<p>Abstract</p> <p>Background</p> <p>This study is a comparative epigenetic evaluation of the methylation status of the <it>DLC1 </it>tumor suppressor gene in naturally-occurring canine lymphoma. Canine non-Hodgkin's lymphoma (NHL) has been proposed to be a relevant preclinical model that occurs spontaneously and may share causative factors with human NHL due to a shared home environment. The canine <it>DLC1 </it>mRNA sequence was derived from normal tissue. Using lymphoid samples from 21 dogs with NHL and 7 normal dogs, the methylation status of the promoter CpG island of the gene was defined for each sample using combined bisulfite restriction analysis (COBRA), methylation-specific PCR (MSP), and bisulfite sequencing methods. Relative gene expression was determined using real-time PCR.</p> <p>Results</p> <p>The mRNA sequence of canine <it>DLC1 </it>is highly similar to the human orthologue and contains all protein functional groups, with 97% or greater similarity in functional regions. Hypermethylation of the 5' and 3' flanking regions of the promoter was statistically significantly associated with the NHL phenotype, but was not associated with silencing of expression or differences in survival.</p> <p>Conclusion</p> <p>The canine <it>DLC1 </it>is constructed highly similarly to the human gene, which has been shown to be an important tumor suppressor in many forms of cancer. As in human NHL, the promoter CpG island of <it>DLC1 </it>in canine NHL samples is abnormally hypermethylated, relative to normal lymphoid tissue. This study confirms that hypermethylation occurs in canine cancers, further supporting the use of companion dogs as comparative models of disease for evaluation of carcinogenesis, biomarker diagnosis, and therapy.</p> |
url |
http://www.biomedcentral.com/1471-2156/10/73 |
work_keys_str_mv |
AT rahmatpanahfarah hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT henrycarolynj hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT rissettokerryc hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT taylorkristenh hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT arthurgeraldl hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT berentlindam hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT jabbesmohamed hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT bryanjeffreyn hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT rankinwendiv hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT villamiljosea hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT lewismichaelr hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma AT caldwellcharlesw hypermethylationoftheitdlc1itcpgislanddoesnotaltergeneexpressionincaninelymphoma |
_version_ |
1724578823633108992 |